Manufacturing challenges surround the use of IgM monoclonal antibodies, but these can be overcome with current technology.
Richard Richieri
Advertisement
Vice President of Manufacturing and Research and Development at Avid Biosciences, Inc.
Articles by Richard Richieri
Advertisement
Latest Updated Articles
Purification of IgM Monoclonal AntibodiesMarch 2nd 2008
Advertisement
Advertisement
Trending on BioPharm International
1
Amgen’s Dazodalibep Reduces Systemic Disease Activity in Phase 3 Sjögren’s Trial
2
FDA Reportedly Pauses National Priority Voucher Pilot and Pauses CRL Publication
3
ImvivaBio’s Dual-Target Allogeneic CAR-T Sustains Lupus Remission Through 12 Months
4
FDA Clears IND for Biolojic’s BD200, the First AI-Designed Multibody ADC to Enter Clinical Trials
5